An observational study in Psychotraumatism, sponsored by University Hospital, Montpellier. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-12-05.
Sponsored by University Hospital, Montpellier · Observational
The increase in psychological violence in our society, but also and above all the search for the best possible reparation for this violence, leads increasingly to questioning the evaluation of psychotraumatisms. In practice, there is no consensus as to the method of assessing psychological repercussions and determining ITI. This topic concerns any physician
The increase in psychological violence in our society (psychological repercussions of physical violence, situations of harassment, psychotraumatism linked to the series of attacks suffered in France), but also and above all, the search for the best possible reparation for this violence The victims and the society), leads increasingly to question the evaluation of psychotraumatisms. In practice, there is no consensus as to the method of assessing psychological repercussions and determining ITI. This topic concerns any physician involved in the care of victims, whether he is a doctor in primary care or in specialized care.
University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients suffering from psychotraumatism.
Exclusion criteria:
Medico-psychological interviews
Study of standardized questionnaires resulting from medico-psychological interviews, the data of which will have been gathered during consultations as part of the care
Time frame: 1 day
No study locations are listed for this record.
Plan to share: Undecided — NC
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier